Compare Stocks: QTEX, CNXU, LNSR, and KEQU

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNXU Conexeu Sciences	$4.25 -4.7%	$8.22	$4.19 ▼ $18.79	$119.34M	N/A	279,491 shs	166,829 shs
KEQU Kewaunee Scientific	$34.53 -1.4%	$36.69	$32.00 ▼ $48.17	$100.48M	0.73	2,271 shs	12,430 shs
LNSR LENSAR	$8.05 -3.1%	$6.90	$4.95 ▼ $12.94	$102.10M	0.97	226,370 shs	70,460 shs
QTEX Inspira Technologies OXY B.H.N.	$0.82 -0.9%	$1.06	$0.28 ▼ $3.85	$29.68M	4.24	2.95 million shs	619,869 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNXU Conexeu Sciences	-4.71%	-19.35%	-42.88%	-62.36%	+424,999,900.00%
KEQU Kewaunee Scientific	-1.43%	-6.17%	-4.61%	-5.99%	-36.86%
LNSR LENSAR	-3.13%	-2.42%	+33.50%	+38.32%	-33.64%
QTEX Inspira Technologies OXY B.H.N.	-0.87%	0.00%	-17.82%	-36.56%	+81,839,900.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNXU Conexeu Sciences	$4.25 -4.7%	$8.22	$4.19 ▼ $18.79	$119.34M	N/A	279,491 shs	166,829 shs
KEQU Kewaunee Scientific	$34.53 -1.4%	$36.69	$32.00 ▼ $48.17	$100.48M	0.73	2,271 shs	12,430 shs
LNSR LENSAR	$8.05 -3.1%	$6.90	$4.95 ▼ $12.94	$102.10M	0.97	226,370 shs	70,460 shs
QTEX Inspira Technologies OXY B.H.N.	$0.82 -0.9%	$1.06	$0.28 ▼ $3.85	$29.68M	4.24	2.95 million shs	619,869 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNXU Conexeu Sciences	-4.71%	-19.35%	-42.88%	-62.36%	+424,999,900.00%
KEQU Kewaunee Scientific	-1.43%	-6.17%	-4.61%	-5.99%	-36.86%
LNSR LENSAR	-3.13%	-2.42%	+33.50%	+38.32%	-33.64%
QTEX Inspira Technologies OXY B.H.N.	-0.87%	0.00%	-17.82%	-36.56%	+81,839,900.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CNXU Conexeu Sciences	2.00	Hold	$20.00	370.59% Upside
KEQU Kewaunee Scientific	2.00	Hold	N/A	N/A
LNSR LENSAR	2.33	Hold	$11.50	42.86% Upside
QTEX Inspira Technologies OXY B.H.N.	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest QTEX, CNXU, LNSR, and KEQU Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/24/2026	QTEX Inspira Technologies OXY B.H.N.	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
8/21/2026	LNSR LENSAR	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D)
8/20/2026	LNSR LENSAR	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$9.00 ➝ $10.00
8/17/2026	CNXU Conexeu Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Sell (E-)
8/13/2026	LNSR LENSAR	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$13.00
8/13/2026	LNSR LENSAR	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$7.00 ➝ $9.00
8/7/2026	LNSR LENSAR	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D+)
6/30/2026	KEQU Kewaunee Scientific	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
6/29/2026	CNXU Conexeu Sciences	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
6/22/2026	CNXU Conexeu Sciences	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$20.00

(Data available from 9/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CNXU Conexeu Sciences	N/A	N/A	N/A	N/A	N/A	N/A
KEQU Kewaunee Scientific	$282M	0.35	$5.87 per share	5.88	$26.80 per share	1.29
LNSR LENSAR	$58.44M	1.69	N/A	N/A	($2.18) per share	-3.69
QTEX Inspira Technologies OXY B.H.N.	$290K	101.45	N/A	N/A	$0.06 per share	13.64

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CNXU Conexeu Sciences	-$3.92M	-$0.11	N/A	N/A	N/A	N/A	N/A	N/A	N/A
KEQU Kewaunee Scientific	$9.62M	$3.22	12.51	N/A	N/A	2.97%	11.75%	4.78%	N/A
LNSR LENSAR	-$34.28M	-$0.33	N/A	N/A	N/A	57.57%	-529.08%	50.03%	11/12/2026 (Estimated)
QTEX Inspira Technologies OXY B.H.N.	-$13.22M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Latest QTEX, CNXU, LNSR, and KEQU Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/9/2026	Q1 2027	KEQU Kewaunee Scientific	N/A	$0.58	N/A	$0.58	N/A	$66.32 million
8/13/2026	Q2 2026	LNSR LENSAR	-$0.1650	$0.10	+$0.2650	$0.10	$14.65 million	$16.50 million
6/23/2026	Q4 2026	KEQU Kewaunee Scientific	N/A	$1.14	N/A	$1.13	N/A	$71.40 million
6/15/2026	Q2 2026	CNXU Conexeu Sciences	N/A	-$0.11	N/A	-$0.11	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CNXU Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
KEQU Kewaunee Scientific	N/A	N/A	N/A	N/A	N/A
LNSR LENSAR	N/A	N/A	N/A	N/A	N/A
QTEX Inspira Technologies OXY B.H.N.	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CNXU Conexeu Sciences	N/A	14.93	14.93
KEQU Kewaunee Scientific	0.53	2.18	1.55
LNSR LENSAR	N/A	2.39	1.13
QTEX Inspira Technologies OXY B.H.N.	0.08	1.56	1.30

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CNXU Conexeu Sciences	N/A
KEQU Kewaunee Scientific	32.69%
LNSR LENSAR	40.15%
QTEX Inspira Technologies OXY B.H.N.	12.72%

Insider Ownership

Company	Insider Ownership
CNXU Conexeu Sciences	N/A
KEQU Kewaunee Scientific	14.10%
LNSR LENSAR	65.80%
QTEX Inspira Technologies OXY B.H.N.	29.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CNXU Conexeu Sciences	4	26.76 million	N/A	N/A
KEQU Kewaunee Scientific	1,231	2.87 million	2.46 million	Not Optionable
LNSR LENSAR	110	12.29 million	4.20 million	Optionable
QTEX Inspira Technologies OXY B.H.N.	20	35.95 million	25.38 million	N/A

QTEX, CNXU, LNSR, and KEQU Headlines

Recent News About These Companies

One of Israel's 3 Largest Defense Companies Begins Immediate Deployment of QTREX Quantum's AME Technology

September 2, 2026 | globenewswire.com

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) Stock Price Down 0.8% - Here's What Happened

September 1, 2026 | americanbankingnews.com

Correction: QTREX Establishes Cryogenic Interconnect Capacity, More Than Four Times the Highest Publicly Disclosed Industry Benchmark

August 31, 2026 | globenewswire.com

QTREX to Unveil Ultra-High-Density Interconnect Architecture Supporting 17,280 Coaxial Lines per Cryogenic Stage at IEEE Quantum Week 2026

August 31, 2026 | globenewswire.com

QTREX Announces Pricing of a $10 Million Registered Direct Offering of Ordinary Shares

August 20, 2026 | globenewswire.com

QTREX's Patent-Pending Technology Achieves First Direct Conversion of 3D-Printed Insulation into Graphene-Like Carbon to Protect Quantum Processors

August 19, 2026 | globenewswire.com

QTREX and U.S. Department of Defense Laboratory Target Q4 2026 to Formalize Joint Quantum Development Program

August 13, 2026 | globenewswire.com

QTREX Proprietary Quantum Interconnect Platform Exceeds Performance Requirements Established by Strategic Partners

July 31, 2026 | globenewswire.com

QTREX Launches Quantum Interconnect Research Program with Commercialization Rights to Project-Generated IP

July 27, 2026 | globenewswire.com

QTREX Announces Clarification to Registration Statement on Form F-1

July 22, 2026 | globenewswire.com

Inspira Technologies Oxy B.h.n.

July 21, 2026 | fool.com

QTREX Appoints Dr. Shlomit Chappel-Ram, Veteran AME R&D Executive, as Independent Director

July 17, 2026 | globenewswire.com

QTREX Secures Commercial Order and Begins Production for Leading International Government-Owned Company

July 14, 2026 | globenewswire.com

QTREX Establishes U.S. Subsidiary to Advance Federal Government Contracting

July 10, 2026 | globenewswire.com

QTREX Announces Operational AME System at U.S. Government Lab with a Quantum Computing Program focused on National Security

July 6, 2026 | globenewswire.com

QTREX Engineers Conductivity Itself to Address Quantum Computing's Cryogenic Heat-Load Barrier

July 1, 2026 | globenewswire.com

QTREX Announces Management Share Purchase Plan

June 22, 2026 | globenewswire.com

QTREX Expands into Quantum Processor Interface with Single-Build Cryogenic Chip Carrier

June 18, 2026 | globenewswire.com

QTREX Quantum's AME Technology Achieves 97% Yield Validation at One of the Largest U.S. Interconnect Manufacturers

June 15, 2026 | globenewswire.com

QTREX Awarded Government Grant to Advance the World's First Native RF Dielectric Material for Quantum Computing

June 9, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

QTEX, CNXU, LNSR, and KEQU Company Descriptions

Conexeu Sciences NASDAQ:CNXU

$4.25 -0.21 (-4.71%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$4.28 +0.03 (+0.59%)

As of 09/10/2026 07:30 PM Eastern

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. --- Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property ("IP") developed over more than a decade at the University of British Columbia (the "University") and the BC Professional Firefighters Burn and Wound Healing Laboratory. In November 2023, the Company entered into a patent assignment agreement with the University pursuant to which the Company acquired an assignment of the University's right, title, and interest in the applicable patents and patent applications related to the underlying technology. The Company's only device candidate is the CXU™ scaffold device candidate, which is in preclinical development and has not been approved or cleared for marketing in any jurisdiction. The Company is conducting preclinical research and preparing for regulatory engagement to evaluate potential use in wound care and other medical applications. Any potential benefits to patients, providers, or healthcare systems have not been established and will require further study and regulatory review. CXU™ is a temperature-responsive, collagen-based extracellular matrix ("ECM") formulation designed to transition from a liquid to a gel-like scaffold following topical application or injection, typically within approximately ten minutes (the "10 Minute Tissue™" concept). The device IP is protected by issued and pending patents and is being evaluated in preclinical studies for its ability to provide an ECM-like environment associated with cellular infiltration, vascularization, and organized tissue remodeling in non-clinical models. We intend to seek U.S. Food and Drug Administration ("FDA") clearance in the United States for the CXU™ scaffold device candidate through the 510(k) premarket notification process as a Class II medical device; however, the FDA has not yet determined the appropriate classification or regulatory pathway for our device candidate, may require additional data or a different pathway, and there can be no assurance that we will obtain clearance or that the device candidate will become commercially available. Our principal executive offices are located in Reno, Nevada.

Kewaunee Scientific NASDAQ:KEQU

$34.53 -0.50 (-1.43%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$34.53 +0.00 (+0.01%)

As of 04:11 AM Eastern

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.

LENSAR NASDAQ:LNSR

$8.05 -0.26 (-3.13%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$8.08 +0.03 (+0.37%)

As of 04:51 AM Eastern

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Inspira Technologies OXY B.H.N. NASDAQ:QTEX

$0.82 -0.01 (-0.87%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$0.84 +0.02 (+2.03%)

As of 07:12 AM Eastern

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest QTEX, CNXU, LNSR, and KEQU Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest QTEX, CNXU, LNSR, and KEQU Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

QTEX, CNXU, LNSR, and KEQU Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

QTEX, CNXU, LNSR, and KEQU Company Descriptions

Conexeu Sciences NASDAQ:CNXU

Kewaunee Scientific NASDAQ:KEQU

LENSAR NASDAQ:LNSR

Inspira Technologies OXY B.H.N. NASDAQ:QTEX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest QTEX, CNXU, LNSR, and KEQU Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest QTEX, CNXU, LNSR, and KEQU Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

QTEX, CNXU, LNSR, and KEQU Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

QTEX, CNXU, LNSR, and KEQU Company Descriptions

Conexeu Sciences NASDAQ:CNXU

Kewaunee Scientific NASDAQ:KEQU

LENSAR NASDAQ:LNSR

Inspira Technologies OXY B.H.N. NASDAQ:QTEX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools